Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Awilly A Chofle"'
Autor:
Kinanga A Magambo, Samuel E Kalluvya, Shikha W Kapoor, Jeremiah Seni, Awilly A Chofle, Daniel W Fitzgerald, Jennifer A Downs
Publikováno v:
Journal of the International AIDS Society, Vol 17, Iss 1, Pp n/a-n/a (2014)
Background Detection of subclinical cryptococcal disease using cryptococcal antigen screening among HIV‐positive individuals presents a potential opportunity for prevention of both clinical disease and death if patients with detectable cryptococcal
Externí odkaz:
https://doaj.org/article/a75d50ab0b9c4766a1338f3add802e44
Autor:
John Changalucha, Mooketsi Molefi, Shabbar Jaffar, Awilly A Chofle, William W. Hope, Gregory P. Bisson, Siprimele F Molloy, Katlego Tsholo, Norah Mawoko, Thomas S. Harrison, Mark W Tenforde, Jeremiah Kidola, David Lawrence, Gabriella Bidwell, Raju K. K. Patel, Tshepo B Leeme, Nametso Tlhako, Joseph N Jarvis, Charles Muthoga
Publikováno v:
CLINICAL INFECTIOUS DISEASES
Background\ud We performed a phase 2 noninferiority trial examining the early fungicidal activity (EFA) of 3 short-course, high-dose liposomal amphotericin B (L-AmB) regimens for cryptococcal meningitis (CM) in Tanzania and Botswana.\ud \ud Methods\u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e58960376a12a51500aeace8ec383231
http://livrepository.liverpool.ac.uk/3026072/1/e00885-18.full.pdf
http://livrepository.liverpool.ac.uk/3026072/1/e00885-18.full.pdf
Autor:
Tariro Makadzange, John Changalucha, Rosie Burton, William W. Hope, Mooketsi Molefi, Miriam Haverkamp, Awilly A Chofle, Thomas S. Harrison, Chiratidzo E. Ndhlovu, Síle F. Molloy, John R. Perfect, Emili Letang, Joseph N Jarvis, Gregory P. Bisson, Graeme Meintjes, Samuel E. Kalluvya, Lukas Fenner, Tshepo B Leeme, Francesca Cainelli, Drew W. Goldberg, Nametso Lekwape
Publikováno v:
Trials
Cryptococcal meningitis (CM) is a leading cause of mortality among HIV-infected individuals in Africa. Poor outcomes from conventional antifungal therapies, unavailability of flucytosine, and difficulties administering 14 days of amphotericin B are k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30f3f1117a8ac06616a18d77e12d121e
https://edoc.unibas.ch/37939/
https://edoc.unibas.ch/37939/
Autor:
Awilly A Chofle, Jeremiah Seni, Samuel E. Kalluvya, Robert N. Peck, Daniel W. Fitzgerald, Benson R. Kidenya, Jennifer A. Downs, John R. Meda
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 66(2)
Background Cryptococcal meningitis (CM) has a mortality rate of ∼70% among HIV-infected adults in low-income countries. Controlling intracranial pressure (ICP) is essential in CM, but it is difficult in low-income countries because manometers and p
Autor:
Hyasinta Jaka, Jennifer A. Downs, Rodrick Kabangila, Luke R. Smart, Warren D. Johnson, Fiona M. Ewings, Daniel W. Fitzgerald, Mheta Koy, Humphrey D. Mazigo, Robert N. Peck, Awilly A Chofle
Publikováno v:
BMC Infectious Diseases
BACKGROUND: Upper gastrointestinal bleeding (UGIB) is a common cause of hospital admissions worldwide. Aetiologies vary by sociodemographics and geography. Retrospective studies of endoscopies in much of Africa have documented oesophageal varices as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::363babb37fe559d9993b56123eef03f9
http://digitallibrary.ihi.or.tz/2700/
http://digitallibrary.ihi.or.tz/2700/
Autor:
Jennifer A. Downs, Daniel W. Fitzgerald, Awilly A Chofle, Shikha W. Kapoor, Kinanga A Magambo, Jeremiah Seni, Samuel E. Kalluvya
Publikováno v:
Journal of the International AIDS Society
Background : Detection of subclinical cryptococcal disease using cryptococcal antigen screening among HIV-positive individuals presents a potential opportunity for prevention of both clinical disease and death if patients with detectable cryptococcal
Autor:
Stott KE; Antimicrobial Pharmacodynamics and Therapeutics, Department of Pharmacology, University of Liverpool, UK.; Malawi Liverpool Wellcome Programme, Kamuzu University of Health Sciences, Malawi., Moyo M; Malawi Liverpool Wellcome Programme, Kamuzu University of Health Sciences, Malawi.; Department of Medicine, Kamuzu University of Health Sciences, Malawi., Ahmadu A; Malawi Liverpool Wellcome Programme, Kamuzu University of Health Sciences, Malawi., Kajanga C; Malawi Liverpool Wellcome Programme, Kamuzu University of Health Sciences, Malawi., Gondwe E; Malawi Liverpool Wellcome Programme, Kamuzu University of Health Sciences, Malawi., Chimang'anga W; Malawi Liverpool Wellcome Programme, Kamuzu University of Health Sciences, Malawi., Chasweka M; Malawi Liverpool Wellcome Programme, Kamuzu University of Health Sciences, Malawi., Leeme TB; Botswana-University of Pennsylvania Partnership, Gaborone, Botswana., Molefi M; University of Botswana, Gaborone, Botswana., Chofle A; National Institute of Medical Research, Mwanza, Tanzania., Bidwell G; National Institute of Medical Research, Mwanza, Tanzania., Changalucha J; National Institute of Medical Research, Mwanza, Tanzania., Unsworth J; Antimicrobial Pharmacodynamics and Therapeutics, Department of Pharmacology, University of Liverpool, UK., Jimenez-Valverde A; Antimicrobial Pharmacodynamics and Therapeutics, Department of Pharmacology, University of Liverpool, UK., Lawrence DS; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Mwandumba HC; Malawi Liverpool Wellcome Programme, Kamuzu University of Health Sciences, Malawi.; Department of Medicine, Kamuzu University of Health Sciences, Malawi.; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK., Lalloo DG; Liverpool School of Tropical Medicine, Liverpool, UK., Harrison TS; Institute of Infection and Immunity, St George's University Hospital, London, UK.; Medical Research Council Centre for Medical Mycology, University of Exeter, Exeter, UK., Jarvis JN; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Hope W; Antimicrobial Pharmacodynamics and Therapeutics, Department of Pharmacology, University of Liverpool, UK., Märtson AG; Antimicrobial Pharmacodynamics and Therapeutics, Department of Pharmacology, University of Liverpool, UK.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2022 Dec 23; Vol. 78 (1), pp. 276-283.